Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

Author:

Page David B1ORCID,Broeckx Glenn23,Jahangir Chowdhury Arif4ORCID,Verbandt Sara5,Gupta Rajarsi R6ORCID,Thagaard Jeppe78,Khiroya Reena9,Kos Zuzana10,Abduljabbar Khalid11,Acosta Haab Gabriela12,Acs Balazs1314,Akturk Guray15,Almeida Jonas S16,Alvarado‐Cabrero Isabel17,Azmoudeh‐Ardalan Farid18,Badve Sunil19,Baharun Nurkhairul Bariyah20,Bellolio Enrique R21,Bheemaraju Vydehi22,Blenman Kim RM2324,Botinelly Mendonça Fujimoto Luciana25,Bouchmaa Najat26,Burgues Octavio27,Cheang Maggie Chon U28,Ciompi Francesco29,Cooper Lee AD30,Coosemans An31,Corredor Germán32,Dantas Portela Flavio Luis33ORCID,Deman Frederik2,Demaria Sandra3435,Dudgeon Sarah N36,Elghazawy Mahmoud3738ORCID,Ely Scott39,Fernandez‐Martín Claudio40,Fineberg Susan41,Fox Stephen B42,Gallagher William M4,Giltnane Jennifer M43,Gnjatic Sacha44,Gonzalez‐Ericsson Paula I45ORCID,Grigoriadis Anita4647ORCID,Halama Niels48,Hanna Matthew G49,Harbhajanka Aparna50,Hardas Alexandros51ORCID,Hart Steven N52ORCID,Hartman Johan1453ORCID,Hewitt Stephen54,Hida Akira I55,Horlings Hugo M56,Husain Zaheed57,Hytopoulos Evangelos58,Irshad Sheeba59,Janssen Emiel AM6061,Kahila Mohamed62,Kataoka Tatsuki R63ORCID,Kawaguchi Kosuke64,Kharidehal Durga22,Khramtsov Andrey I65,Kiraz Umay6061,Kirtani Pawan66,Kodach Liudmila L67,Korski Konstanty68,Kovács Anikó6970,Laenkholm Anne‐Vibeke7172,Lang‐Schwarz Corinna73,Larsimont Denis74,Lennerz Jochen K75,Lerousseau Marvin767778,Li Xiaoxian79,Ly Amy80,Madabhushi Anant81,Maley Sai K82,Manur Narasimhamurthy Vidya83,Marks Douglas K84,McDonald Elizabeth S85,Mehrotra Ravi8687,Michiels Stefan88,Minhas Fayyaz ul Amir Afsar89,Mittal Shachi90,Moore David A91,Mushtaq Shamim92,Nighat Hussain93,Papathomas Thomas9495,Penault‐Llorca Frederique96,Perera Rashindrie D9798,Pinard Christopher J99100101102,Pinto‐Cardenas Juan Carlos103,Pruneri Giancarlo104105,Pusztai Lajos106107,Rahman Arman4,Rajpoot Nasir Mahmood108,Rapoport Bernardo Leon109110,Rau Tilman T111ORCID,Reis‐Filho Jorge S112ORCID,Ribeiro Joana M113,Rimm David62114ORCID,Vincent‐Salomon Anne115,Salto‐Tellez Manuel116117,Saltz Joel118,Sayed Shahin119,Siziopikou Kalliopi P120,Sotiriou Christos121122,Stenzinger Albrecht123,Sughayer Maher A124,Sur Daniel125,Symmans Fraser126,Tanaka Sunao127,Taxter Timothy128,Tejpar Sabine5,Teuwen Jonas129,Thompson E Aubrey130,Tramm Trine131,Tran William T132,van der Laak Jeroen133,van Diest Paul J134135,Verghese Gregory E4647ORCID,Viale Giuseppe136,Vieth Michael137,Wahab Noorul138ORCID,Walter Thomas767778,Waumans Yannick139,Wen Hannah Y49,Yang Wentao140,Yuan Yinyin141,Adams Sylvia84142,Bartlett John Mark Seaverns143,Loibl Sibylle144,Denkert Carsten145,Savas Peter98146,Loi Sherene98147,Salgado Roberto298,Specht Stovgaard Elisabeth148149

Affiliation:

1. Earle A Chiles Research Institute Providence Cancer Institute Portland OR USA

2. Department of Pathology GZA‐ZNA Hospitals Antwerp Belgium

3. Centre for Oncological Research (CORE), MIPPRO, Faculty of Medicine Antwerp University Antwerp Belgium

4. UCD School of Biomolecular and Biomedical Science University College Dublin Dublin Ireland

5. Digestive Oncology, Department of Oncology KU Leuven Leuven Belgium

6. Department of Biomedical Informatics Stony Brook University Stony Brook NY USA

7. Technical University of Denmark Kongens Lyngby Denmark

8. Visiopharm A/S Hørsholm Denmark

9. Department of Cellular Pathology University College Hospital London UK

10. Department of Pathology and Laboratory Medicine, BC Cancer Vancouver Centre University of British Columbia Vancouver BC Canada

11. Centre for Evolution and Cancer The Institute of Cancer Research London UK

12. Hospital Maria Curie Buenos Aires Argentina

13. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

14. Clinical Pathology and Cancer Diagnostics Karolinska University Hospital Stockholm Sweden

15. Translational Molecular Biomarkers Merck & Co Inc Kenilworth NJ USA

16. National Cancer Institute Division of Cancer Epidemiology and Genetics (DCEG) Rockville MD USA

17. Oncology Hospital Star Medica Centro Mexico

18. Tehran University of Medical Sciences Tehran Iran

19. Pathology and Laboratory Medicine Emory University School of Medicine, Emory University Winship Cancer Institute Atlanta GA USA

20. The National University of Malaysia Kuala Lumpur Malaysia

21. Departamento de Anatomía Patológica, Facultad de Medicina Universidad de La Frontera Temuco Chile

22. Department of Pathology Narayana Medical College Nellore India

23. Internal Medicine Section of Medical Oncology and Yale Cancer Center Yale School of Medicine New Haven CT USA

24. Computer Science Yale School of Engineering and Applied Science New Haven CT USA

25. Amazonas Federal University Manaus Brazil

26. Institute of Biological Sciences, Faculty of Medical Sciences Mohammed VI Polytechnic University (UM6P) Ben‐Guerir Morocco

27. Pathology Department Hospital Cliníco Universitario de Valencia/Incliva Valencia Spain

28. Head of Integrative Genomics Analysis in Clinical Trials, ICR‐CTSU, Division of Clinical Studies Institute of Cancer Research London UK

29. Radboud University Medical Center Department of Pathology Nijmegen The Netherlands

30. Department of Pathology Northwestern Feinberg School of Medicine Chicago IL USA

31. Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy KU Leuven Leuven Belgium

32. Biomedical Engineering Department Emory University Atlanta GA USA

33. Hospital Universitário Getúlio Vargas Manaus Brazil

34. Department of Radiation Oncology Weill Cornell Medical College New York NY USA

35. Department of Pathology Weill Cornell Medicine New York NY USA

36. Conputational Biology and Bioinformatics Yale University New Haven CT USA

37. University of Surrey Guildford UK

38. Ain Shams University Cairo Egypt

39. Translational Pathology Translational Sciences and Diagnostics/Translational Medicine/R&D, Bristol Myers Squibb Princeton NJ USA

40. Instituto Universitario de Investigación en Tecnología Centrada en el Ser Humano, HUMAN‐tech Universitat Politècnica de València Valencia Spain

41. Montefiore Medical Center and the Albert Einstein College of Medicine New York NY USA

42. Department of Pathology, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia

43. Genentech South San Francisco CA USA

44. Department of Oncological Sciences, Medicine Hem/Onc, and Pathology, Tisch Cancer Institute – Precision Immunology Institute Icahn School of Medicine at Mount Sinai New York NY USA

45. Department of Medicine Vanderbilt University Medical Center Nashville TN USA

46. Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine King's College London London UK

47. Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine King's College London London UK

48. Translational Immunotherapy German Cancer Research Center Heidelberg Germany

49. Memorial Sloan Kettering Cancer Center New York NY USA

50. Case Western University Cleveland OH USA

51. Pathobiology & Population Sciences The Royal Veterinary College London UK

52. Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA

53. Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

54. Department of Pathology, Center for Cancer Research, National Cancer Institute National Institutes of Health Bethesda MD USA

55. Department of Pathology Matsuyama Shimin Hospital Matsuyama Japan

56. Division of Pathology Netherlands Cancer Institute (NKI) Amsterdam The Netherlands

57. Praava Health Dhaka Bangladesh

58. iRhythm Technologies Inc. San Francisco CA USA

59. King's College London & Guy's & St Thomas’ NHS Trust London UK

60. Department of Pathology Stavanger University Hospital Stavanger Norway

61. Department of Chemistry, Bioscience and Environmental Technology University of Stavanger Stavanger Norway

62. Department of Pathology Yale University School of Medicine New Haven CT USA

63. Department of Pathology Iwate Medical University Iwate Japan

64. Department of Breast Surgery Kyoto University Graduate School of Medicine Kyoto Japan

65. Pathology and Laboratory Medicine Ann & Robert H. Lurie Children's Hospital of Chicago Chicago IL USA

66. Department of Histopathology Aakash Healthcare Super Speciality Hospital New Delhi India

67. Department of Pathology Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam The Netherlands

68. Data, Analytics and Imaging, Product Development F.Hoffmann‐La Roche AG Basel Switzerland

69. Department of Clinical Pathology Sahlgrenska University Hospital Gothenburg Sweden

70. Institute of Biomedicine, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

71. Surgical Pathology Zealand University Hospital Roskilde Denmark

72. Surgical Pathology University of Copenhagen Copenhagen Denmark

73. Institute of Pathology, Klinikum Bayreuth GmbH Friedrich‐Alexander‐University Erlangen‐Nuremberg Bayreuth Germany

74. Institut Jules Bordet Université Libre de Bruxelles Brussels Belgium

75. Center for Integrated Diagnostics Massachusetts General Hospital/Harvard Medical School Boston MA USA

76. Centre for Computational Biology (CBIO) Mines Paris, PSL University Paris France

77. Institut Curie PSL University Paris France

78. INSERM, U900 Paris France

79. Pathology and Laboratory Medicine Emory University Atlanta GA USA

80. Department of Pathology Massachusetts General Hospital Boston MA USA

81. Biomedical Engineering, Radiology and Imaging Sciences, Biomedical Informatics, Pathology Georgia Institute of Technology and Emory University Atlanta GA USA

82. NRG Oncology/NSABP Foundation Pittsburgh PA USA

83. Manipal Hospitals Bangalore India

84. Perlmutter Cancer Center NYU Langone Health New York NY USA

85. Breast Cancer Translational Research Group University of Pennsylvania Philadelphia PA USA

86. Indian Cancer Genome Atlas Pune India

87. Centre for Health, Innovation and Policy Foundation Noida India

88. Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat U1018, Inserm University Paris‐Saclay, Ligue Contre le Cancer labeled Team Villejuif France

89. Tissue Image Analytics Centre, Warwick Cancer Research Centre, PathLAKE Consortium, Department of Computer Science University of Warwick Coventry UK

90. Department of Chemical Engineering, Department of Laboratory Medicine and Pathology University of Washington Seattle WA USA

91. CRUK Lung Cancer Centre of Excellence, UCLH London UK

92. Department of Biochemistry Ziauddin University Karachi Pakistan

93. Pathology and Laboratory Medicine All India Institute of Medical Sciences Raipur India

94. Institute of Metabolism and Systems Research University of Birmingham Birmingham UK

95. Department of Clinical Pathology Drammen Sykehus, Vestre Viken HF Drammen Norway

96. Centre Jean Perrin, INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques Université Clermont Auvergne Clermont‐Ferrand France

97. School of Electrical, Mechanical and Infrastructure Engineering University of Melbourne Melbourne VIC Australia

98. Division of Cancer Research Peter MacCallum Cancer Centre Melbourne VIC Australia

99. Radiogenomics Laboratory Sunnybrook Health Sciences Centre Toronto ON Canada

100. Department of Clinical Studies, Ontario Veterinary College University of Guelph Guelph ON Canada

101. Department of Oncology Lakeshore Animal Health Partners Mississauga ON Canada

102. Centre for Advancing Responsible and Ethical Artificial Intelligence (CARE‐AI) University of Guelph Guelph ON Canada

103. Diagnostico de Salud Animal SA Ciudad de México Mexico

104. Department of Pathology and Laboratory Medicine Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

105. Faculty of Medicine and Surgery University of Milan Milan Italy

106. Yale Cancer Center New Haven CT USA

107. Department of Medical Oncology Yale School of Medicine New Haven CT USA

108. University of Warwick Warwick UK

109. The Medical Oncology Centre of Rosebank Johannesburg South Africa

110. Department of Immunology, Faculty of Health Sciences University of Pretoria Pretoria South Africa

111. Institute of Pathology University Hospital Düsseldorf and Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

112. Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center New York NY USA

113. Département de Médecine Oncologique Institute Gustave Roussy Villejuif France

114. Department of Medicine Yale University School of Medicine New Haven CT USA

115. Department of Diagnostic and Theranostic Medicine Institut Curie, University Paris‐Sciences et Lettres Paris France

116. Integrated Pathology Unit Institute of Cancer Research London UK

117. Precision Medicine Centre Queen's University Belfast Belfast UK

118. Department of Biomedical Informatics Stony Brook Medicine New York NY USA

119. Department of Pathology Aga Khan University Nairobi Kenya

120. Department of Pathology, Section of Breast Pathology Northwestern University Feinberg School of Medicine Chicago IL USA

121. Breast Cancer Translational Research Laboratory J.‐C. Heuson, Institut Jules Bordet Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB) Brussels Belgium

122. Medical Oncology Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB) Université Libre de Bruxelles Brussels Belgium

123. Institute of Pathology University Hospital Heidelberg, Centers for Personalized Medicine (ZPM) Heidelberg Germany

124. King Hussein Cancer Center Amman Jordan

125. Department of Medical Oncology University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj‐Napoca Romania

126. University of Texas MD Anderson Cancer Center Houston TX USA

127. Kyoto University Kyoto Japan

128. Tempus Labs Chicago IL USA

129. AI for Oncology Lab Netherlands Cancer Institute Amsterdam The Netherlands

130. Mayo Clinic Jacksonville FL USA

131. Pathology, and Institute of Clinical Medicine Aarhus University Hospital Aarhus Denmark

132. Department of Radiation Oncology University of Toronto and Sunnybrook Health Sciences Centre Toronto ON Canada

133. Department of Pathology Radboud University Medical Center Nijmegen The Netherlands

134. Department of Pathology University Medical Center Utrecht Utrecht The Netherlands

135. Johns Hopkins Oncology Center Baltimore MD USA

136. Department of Pathology European Institute of Oncology & University of Milan Milan Italy

137. Institute of Pathology Klinikum Bayreuth GmbH, Friedrich‐Alexander‐University Erlangen‐Nuremberg Bayreuth Germany

138. Tissue Image Analytics Centre, Department of Computer Science University of Warwick Coventry UK

139. CellCarta NV Antwerp Belgium

140. Fudan Medical University Shanghai Cancer Center Shanghai PR China

141. Translational Molecular Pathology, Division of Pathology and Laboratory Medicine The University of Texas MD Anderson Cancer Center Houston TX USA

142. Department of Medicine NYU Grossman School of Medicine Manhattan NY USA

143. University of Edinburgh Edinburgh UK

144. Department of Medicine and Research German Breast Group Neu‐Isenburg Germany

145. Institut für Pathologie Philipps‐Universität Marburg und Universitätsklinikum Marburg Marburg Germany

146. Sir Peter MacCallum Department of Medical Oncology University of Melbourne Melbourne VIC Australia

147. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia

148. Department of Pathology Herlev and Gentofte Hospital Herlev Denmark

149. Faculty of Health and Medical Sciences Copenhagen University Copenhagen Denmark

Abstract

AbstractModern histologic imaging platforms coupled with machine learning methods have provided new opportunities to map the spatial distribution of immune cells in the tumor microenvironment. However, there exists no standardized method for describing or analyzing spatial immune cell data, and most reported spatial analyses are rudimentary. In this review, we provide an overview of two approaches for reporting and analyzing spatial data (raster versus vector‐based). We then provide a compendium of spatial immune cell metrics that have been reported in the literature, summarizing prognostic associations in the context of a variety of cancers. We conclude by discussing two well‐described clinical biomarkers, the breast cancer stromal tumor infiltrating lymphocytes score and the colon cancer Immunoscore, and describe investigative opportunities to improve clinical utility of these spatial biomarkers. © 2023 The Pathological Society of Great Britain and Ireland.

Funder

Svenska Sällskapet för Medicinsk Forskning

DOD Peer Reviewed Cancer Research Program

U.S. Department of Defense

National Institutes of Health

National Health and Medical Research Council

Higher Education Authority

Irish Cancer Society

Breast Cancer Now

Cancer Research UK

Japan Society for the Promotion of Science

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

U.S. Department of Veterans Affairs

DOD Prostate Cancer Research Program

AstraZeneca

Engineering and Physical Sciences Research Council

Fondation ARC pour la Recherche sur le Cancer

Peter MacCallum Cancer Centre

Breast Cancer Research Foundation

KU Leuven

Ministerie van Volksgezondheid, Welzijn en Sport

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3